London
· Delayed Price · Currency is GBP · Price in USD Atara Biotherapeutics Statistics
Total Valuation
LON:0HIY has a market cap or net worth of GBP 33.57 million. The enterprise value is 43.26 million.
| Market Cap | 33.57M |
| Enterprise Value | 43.26M |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 5.86M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +76.77% |
| Shares Change (QoQ) | +43.45% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.30 |
| PS Ratio | 0.22 |
| PB Ratio | -0.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.02, with an EV/FCF ratio of -0.83.
| EV / Earnings | -3.57 |
| EV / Sales | 0.29 |
| EV / EBITDA | 4.02 |
| EV / EBIT | n/a |
| EV / FCF | -0.83 |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.87 |
| Debt / FCF | -0.40 |
| Interest Coverage | -1.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.55% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -58.55% |
| Revenue Per Employee | 1.01M |
| Profits Per Employee | -79,124 |
| Employee Count | 153 |
| Asset Turnover | 1.76 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.03% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -57.03% |
| 50-Day Moving Average | 6.72 |
| 200-Day Moving Average | 8.86 |
| Relative Strength Index (RSI) | 57.42 |
| Average Volume (20 Days) | 776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0HIY had revenue of GBP 154.59 million and -12.11 million in losses. Loss per share was -1.38.
| Revenue | 154.59M |
| Gross Profit | 9.70M |
| Operating Income | -6.41M |
| Pretax Income | -12.13M |
| Net Income | -12.11M |
| EBITDA | -2.19M |
| EBIT | -6.41M |
| Loss Per Share | -1.38 |
Balance Sheet
The company has 10.71 million in cash and 20.67 million in debt, giving a net cash position of -9.96 million.
| Cash & Cash Equivalents | 10.71M |
| Total Debt | 20.67M |
| Net Cash | -9.96M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -42.63M |
| Book Value Per Share | -7.20 |
| Working Capital | -16.03M |
Cash Flow
In the last 12 months, operating cash flow was -52.05 million and capital expenditures -92,105, giving a free cash flow of -52.14 million.
| Operating Cash Flow | -52.05M |
| Capital Expenditures | -92,105 |
| Free Cash Flow | -52.14M |
| FCF Per Share | n/a |
Margins
Gross margin is 6.28%, with operating and profit margins of -4.15% and -7.83%.
| Gross Margin | 6.28% |
| Operating Margin | -4.15% |
| Pretax Margin | -7.85% |
| Profit Margin | -7.83% |
| EBITDA Margin | -1.42% |
| EBIT Margin | -4.15% |
| FCF Margin | n/a |
Dividends & Yields
LON:0HIY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.77% |
| Shareholder Yield | -76.77% |
| Earnings Yield | -36.06% |
| FCF Yield | -155.30% |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |